N/A N=103

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up

Diabetes Mellitus · Hypertension · Ischemic Heart Disease · Stroke

Bottom Line

View on ClinicalTrials.gov: NCT01412554 ↗

Enrolled (actual)

103

Serious AEs

0.0%

Results posted

Oct 2019

Primary outcome: Primary: Exploring Insulin Sensitivity After 10-20 Years of Follow-up — 7 mg/kg/min — p=<0.05

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult · 30+ yrs
Sex: Male
Sponsor: Oslo University Hospital
Primary completion: Mar 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Exploring Insulin Sensitivity After 10-20 Years of Follow-up	—	—
PRIMARY Exploring Insulin Sensitivity After 10-20 Years of Follow-up	—	—
SECONDARY Sympathoadrenal Activity During Rest and Stress Tests	—	—
SECONDARY Echocardiography	—	—
SECONDARY Ultrasound Abdomen	—	—

Summary

The purpose of this study is to identify risk factors for insulin resistance and to investigate the influence of insulin sensitivity on development of cardiovascular risk markers like blood pressure, heart rate, body build (weight, BMI, waist-hip ratio, skinfold thickness), reduced insulin sensitivity, diabetes mellitus, dyslipidaemia, and sympathoadrenal activity or manifest cardiovascular disease among young men during 10-20 years.

Eligibility Criteria

Inclusion Criteria

Completed hyperinsulinemic glucose clamp

Exclusion Criteria

Missing agreement
No contact information

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01412554). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.